Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research focused on Rheumatoid arthritis and Lymphoma, with related work in Genome-wide association study, Missense mutation, Cancer. Notable publications include 'Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study', 'Lymphoma development in patients with autoimmune and inflammatory disorders – What are the driving forces?', and 'Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial'.
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?
Reduced expression of <scp>TRIM</scp>21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden
Lymphoma development in patients with autoimmune and inflammatory disorders – What are the driving forces?
Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study